Qing Ni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Qing Ni has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Yupeng Chen
Department of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China
9 shared publicationsShan Zhang
Department of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China
7 shared publicationsZhige Wen
Department of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China
7 shared publicationsYueying Zhang
Department of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China
5 shared publicationsChangheng Song
Department of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China
3 shared publications- Shan Zhang
Department of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China
3 shared publications
Latest Publications
- Open Access
- 1 April 2026
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 58, 101088
Epigenetic transcriptional regulation of skeletal aging: The emerging role of m6A methylation
- 1 April 2026
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 58, 101088
Open AccessEpigenetic transcriptional regulation of skeletal aging: The emerging role of m6A methylation
- 14 January 2026
- Published by Elsevier in Phytomedicine
- Vol. 152, 157836
Morus alba L. (Sangzhi) alkaloids alleviate diabetic nephropathy by suppressing endoplasmic reticulum stress and modulating AMPK-associated phosphatidylethanolamine content
- 14 January 2026
- Published by Elsevier in Phytomedicine
- Vol. 152, 157836
Morus alba L. (Sangzhi) alkaloids alleviate diabetic nephropathy by suppressing endoplasmic reticulum stress and modulating AMPK-associated phosphatidylethanolamine content
- Open Access
- 27 November 2025
- Published by Springer Nature in European Journal of Medical Research
- Vol. 30 (1)
Neutrophil percentage to albumin ratio and advanced cardiovascular-kidney-metabolic syndrome in diabetes: a machine learning approach
Diabetes mellitus (DM) has become an increasingly significant global health challenge, with rising complications and mortality rates. Patients with DM are
- 27 November 2025
- Published by Springer Nature in European Journal of Medical Research
- Vol. 30 (1)
Open AccessNeutrophil percentage to albumin ratio and advanced cardiovascular-kidney-metabolic syndrome in diabetes: a machine learning approach
Diabetes mellitus (DM) has become an increasingly significant global health challenge, with rising complications and mortality rates. Patients with DM are
- 5 July 2025
- Published by Elsevier in Phytomedicine
- Vol. 148, 157043
Jinkui Shenqi pills improve pancreatic islet function in diabetes by modulating macrophage inflammation through the succinate/HIF1α axis
- 5 July 2025
- Published by Elsevier in Phytomedicine
- Vol. 148, 157043
Jinkui Shenqi pills improve pancreatic islet function in diabetes by modulating macrophage inflammation through the succinate/HIF1α axis
- 19 May 2025
- Published by Elsevier in Phytomedicine
- Vol. 145, 156776
Keluoxin reduces renal lipid deposition in diabetic nephropathy via AMPK/NF-κB-mediated mtabolic regulation
- 19 May 2025
- Published by Elsevier in Phytomedicine
- Vol. 145, 156776
Keluoxin reduces renal lipid deposition in diabetic nephropathy via AMPK/NF-κB-mediated mtabolic regulation
- Open Access
- 27 March 2025
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 17 (1) , 1-14
Rising tide: the growing global burden and inequalities of early-onset type 2 diabetes among youths aged 15–34 years (1990–2021)
Type 2 diabetes mellitus (T2DM) is increasingly affecting people aged 15–34, posing a serious public health challenge due to its faster progression and higher complication risks. This study examines the global, regional, and national burden of early-onset T2DM from 1990 to 2021, emphasizing trends and disparities across different sociodemographic contexts. Using data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021, we analyzed incidence, prevalence, mortality, disability-adjusted life years (DALYs), years lived with disability (YLDs), and years of life lost (YLLs) in people aged 15–34. Stratifications included age, sex, and the Socio-Demographic Index (SDI). Joinpoint regression significant temporal shifts, and decomposition analysis attributed changes in T2DM burden to factors such as prevalence, population growth, aging, and case fatality rates. Inequality was assessed with the Slope Index of Inequality and Concentration Index. From 1990 to 2021, early-onset T2DM incidence and prevalence rose significantly worldwide, especially in high-SDI regions. Although global mortality and DALYs appeared relatively stable, low-SDI regions showed worrisome increases. Rising T2DM prevalence was the principal driver of mortality and DALYs, notably in low- and middle-SDI regions. Inequality analyses indicated widening disparities, with higher incidence and prevalence in high-SDI countries and more severe outcomes in low-SDI countries. The global burden of early-onset T2DM among youths is escalating, with significant disparities across different sociodemographic levels. The findings underscore the urgent need for targeted public health interventions. Future research should focus on the underlying factors driving these trends and explore strategies for effective prevention and management of early-onset T2DM.
- 27 March 2025
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 17 (1) , 1-14
Open AccessRising tide: the growing global burden and inequalities of early-onset type 2 diabetes among youths aged 15–34 years (1990–2021)
Type 2 diabetes mellitus (T2DM) is increasingly affecting people aged 15–34, posing a serious public health challenge due to its faster progression and higher complication risks. This study examines the global, regional, and national burden of early-onset T2DM from 1990 to 2021, emphasizing trends and disparities across different sociodemographic contexts. Using data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021, we analyzed incidence, prevalence, mortality, disability-adjusted life years (DALYs), years lived with disability (YLDs), and years of life lost (YLLs) in people aged 15–34. Stratifications included age, sex, and the Socio-Demographic Index (SDI). Joinpoint regression significant temporal shifts, and decomposition analysis attributed changes in T2DM burden to factors such as prevalence, population growth, aging, and case fatality rates. Inequality was assessed with the Slope Index of Inequality and Concentration Index. From 1990 to 2021, early-onset T2DM incidence and prevalence rose significantly worldwide, especially in high-SDI regions. Although global mortality and DALYs appeared relatively stable, low-SDI regions showed worrisome increases. Rising T2DM prevalence was the principal driver of mortality and DALYs, notably in low- and middle-SDI regions. Inequality analyses indicated widening disparities, with higher incidence and prevalence in high-SDI countries and more severe outcomes in low-SDI countries. The global burden of early-onset T2DM among youths is escalating, with significant disparities across different sociodemographic levels. The findings underscore the urgent need for targeted public health interventions. Future research should focus on the underlying factors driving these trends and explore strategies for effective prevention and management of early-onset T2DM.
- Open Access
- 7 May 2024
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1393392
The role and therapeutic potential of macrophages in the pathogenesis of diabetic cardiomyopathy
This review provides a comprehensive analysis of the critical role played by macrophages and their underlying mechanisms in the progression of diabetic cardiomyopathy (DCM). It begins by discussing the origins and diverse subtypes of macrophages, elucidating their spatial distribution and modes of intercellular communication, thereby emphasizing their significance in the pathogenesis of DCM. The review then delves into the intricate relationship between macrophages and the onset of DCM, particularly focusing on the epigenetic regulatory mechanisms employed by macrophages in the context of DCM condition. Additionally, the review discusses various therapeutic strategies aimed at targeting macrophages to manage DCM. It specifically highlights the potential of natural food components in alleviating diabetic microvascular complications and examines the modulatory effects of existing hypoglycemic drugs on macrophage activity. These findings, summarized in this review, not only provide fresh insights into the role of macrophages in diabetic microvascular complications but also offer valuable guidance for future therapeutic research and interventions in this field.
- 7 May 2024
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1393392
Open AccessThe role and therapeutic potential of macrophages in the pathogenesis of diabetic cardiomyopathy
This review provides a comprehensive analysis of the critical role played by macrophages and their underlying mechanisms in the progression of diabetic cardiomyopathy (DCM). It begins by discussing the origins and diverse subtypes of macrophages, elucidating their spatial distribution and modes of intercellular communication, thereby emphasizing their significance in the pathogenesis of DCM. The review then delves into the intricate relationship between macrophages and the onset of DCM, particularly focusing on the epigenetic regulatory mechanisms employed by macrophages in the context of DCM condition. Additionally, the review discusses various therapeutic strategies aimed at targeting macrophages to manage DCM. It specifically highlights the potential of natural food components in alleviating diabetic microvascular complications and examines the modulatory effects of existing hypoglycemic drugs on macrophage activity. These findings, summarized in this review, not only provide fresh insights into the role of macrophages in diabetic microvascular complications but also offer valuable guidance for future therapeutic research and interventions in this field.
- Open Access
- 2 February 2024
- Published by Elsevier in Phytomedicine
- Vol. 126, 155297
Jinkui Shenqi pills ameliorate diabetes by regulating hypothalamic insulin resistance and POMC/AgRP expression and activity
- 2 February 2024
- Published by Elsevier in Phytomedicine
- Vol. 126, 155297
Open AccessJinkui Shenqi pills ameliorate diabetes by regulating hypothalamic insulin resistance and POMC/AgRP expression and activity
- Open Access
- 28 January 2024
- Published by Elsevier in Phytomedicine
- Vol. 128, 155396
Enhancing β-cell function and identity in type 2 diabetes: The protective role of Coptis deltoidea C. Y. Cheng et Hsiao via glucose metabolism modulation and AMPK signaling activation
- 28 January 2024
- Published by Elsevier in Phytomedicine
- Vol. 128, 155396
Open AccessEnhancing β-cell function and identity in type 2 diabetes: The protective role of Coptis deltoidea C. Y. Cheng et Hsiao via glucose metabolism modulation and AMPK signaling activation